English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 11 Help

Selected(0)Clear Items/Page:    Sort:
Tauroursodeoxycholic Acid Reverses Dextran Sulfate Sodium-Induced Colitis in Mice via Modulation of Intestinal Barrier Dysfunction and Microbiome Dysregulation Journal article
Luo, Longbiao, Zhao, Yi, Zhang, Guangji, Dong, Sijing, Xu, Yin Yue, Shi, Hehe, Zhang, Menggai, Liu, Xue, Wang, Sicen, Luo, Hua, Jing, Wanghui. Tauroursodeoxycholic Acid Reverses Dextran Sulfate Sodium-Induced Colitis in Mice via Modulation of Intestinal Barrier Dysfunction and Microbiome Dysregulation[J]. Journal of Pharmacology and Experimental Therapeutics, 2024, 390(1), 116-124.
Authors:  Luo, Longbiao;  Zhao, Yi;  Zhang, Guangji;  Dong, Sijing;  Xu, Yin Yue; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.1/3.3 | Submit date：2024/07/04
Berberine upregulates P-glycoprotein in human caco-2 cells and in an experimental model of colitis in the rat via activation of Nrf2-dependent mechanismss Journal article
Jing W., Safarpour Y., Zhang T., Guo P., Chen G., Wu X., Fu Q., Wang Y.. Berberine upregulates P-glycoprotein in human caco-2 cells and in an experimental model of colitis in the rat via activation of Nrf2-dependent mechanismss[J]. Journal of Pharmacology and Experimental Therapeutics, 2018, 366(2), 332.
Authors:  Jing W.;  Safarpour Y.;  Zhang T.;  Guo P.;  Chen G.; et al.
Favorite | TC[WOS]:47 TC[Scopus]:52  IF:3.1/3.3 | Submit date：2018/10/31
Flavopiridol Inhibits TGF-β-Stimulated Biglycan Synthesis by Blocking Linker Region Phosphorylation and Nuclear Translocation of Smad2 Journal article
Muhamad A. Rostam, Aravindra Shajimoon, Danielle Kamato, Partha Mitra, Terrence J. Piva, Robel Getachew, Yingnan Cao, Wenhua Zheng, Narin Osman, Peter J. Little. Flavopiridol Inhibits TGF-β-Stimulated Biglycan Synthesis by Blocking Linker Region Phosphorylation and Nuclear Translocation of Smad2[J]. Journal of pharmacology and experimental therapeutics, 2018, 156-164.
Authors:  Muhamad A. Rostam;  Aravindra Shajimoon;  Danielle Kamato;  Partha Mitra;  Terrence J. Piva; et al.
Favorite |   IF:3.1/3.3 | Submit date：2022/08/31
Flavopiridol  Tgf-β  
Flavopiridol Inhibits TGF-beta-Stimulated Biglycan Synthesis by Blocking Linker Region Phosphorylation and Nuclear Translocation of Smad2 Journal article
Rostam, Muhamad A., Shajimoon, Aravindra, Kamato, Danielle, Mitra, Partha, Piva, Terrence J., Getachew, Robel, Cao, Yingnan, Zheng, Wenhua, Osman, Narin, Little, Peter J.. Flavopiridol Inhibits TGF-beta-Stimulated Biglycan Synthesis by Blocking Linker Region Phosphorylation and Nuclear Translocation of Smad2[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365(1), 156-164.
Authors:  Rostam, Muhamad A.;  Shajimoon, Aravindra;  Kamato, Danielle;  Mitra, Partha;  Piva, Terrence J.; et al.
Favorite | TC[WOS]:25 TC[Scopus]:24  IF:3.1/3.3 | Submit date：2018/10/30
Flavopiridol inhibits TGF-b-stimulated biglycan synthesis by blocking linker region phosphorylation and nuclear translocation of Smad2 Journal article
Rostam M.A., Shajimoon A., Kamato D., Mitra P., Piva T.J., Getachew R., Cao Y., Zheng W., Osman N., Little P.J.. Flavopiridol inhibits TGF-b-stimulated biglycan synthesis by blocking linker region phosphorylation and nuclear translocation of Smad2[J]. Journal of Pharmacology and Experimental Therapeutics, 2018, 365(1), 156-164.
Authors:  Rostam M.A.;  Shajimoon A.;  Kamato D.;  Mitra P.;  Piva T.J.; et al.
Favorite | TC[WOS]:25 TC[Scopus]:24 | Submit date：2018/12/21
Novel phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced neuroinflammation by regulation of the cAMP/PKA/CREB signaling pathway and NF-κB inhibition Journal article
Zou Z.-Q., Chen J.-J., Feng H.-F., Cheng Y.-F., Wang H.-T., Zhou Z.-Z., Guo H.-B., Zheng W., Xu J.-P.. Novel phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced neuroinflammation by regulation of the cAMP/PKA/CREB signaling pathway and NF-κB inhibition[J]. Journal of Pharmacology and Experimental Therapeutics, 2017, 362(1), 67-77.
Authors:  Zou Z.-Q.;  Chen J.-J.;  Feng H.-F.;  Cheng Y.-F.;  Wang H.-T.; et al.
Favorite | TC[WOS]:37 TC[Scopus]:40 | Submit date：2018/12/21
Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-kappa B Inhibition Journal article
Zou, Zheng-Qiang, Chen, Jia-Jia, Feng, Hong-Fang, Cheng, Yu-Fang, Wang, Hai-Tao, Zhou, Zhong-Zhen, Guo, Hai-Biao, Zheng, Wenhua, Xu, Jiang-Ping. Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-kappa B Inhibition[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362(1), 67-77.
Authors:  Zou, Zheng-Qiang;  Chen, Jia-Jia;  Feng, Hong-Fang;  Cheng, Yu-Fang;  Wang, Hai-Tao; et al.
Favorite | TC[WOS]:37 TC[Scopus]:40  IF:3.1/3.3 | Submit date：2018/10/30
Uptake and protective effects of ergothioneine in human endothelial cells Journal article
Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte, George P. H. Leung. Uptake and protective effects of ergothioneine in human endothelial cells[J]. Journal of Pharmacology and Experimental Therapeutics, 2014, 350(3), 691-700.
Authors:  Rachel W. S. Li;  C. Yang;  Albert S. M. Sit;  Y. W. Kwan;  Simon M. Y. Lee; et al.
Favorite | TC[WOS]:50 TC[Scopus]:50  IF:3.1/3.3 | Submit date：2018/11/06
Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-D- aspartate receptor antagonists Journal article
Storvik M., Linden A.-M., Kontkanen O., Lakso M., Castren E., Wong G.. Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-D- aspartate receptor antagonists[J]. Journal of Pharmacology and Experimental Therapeutics, 2000, 294(1), 52-60.
Authors:  Storvik M.;  Linden A.-M.;  Kontkanen O.;  Lakso M.;  Castren E.; et al.
Favorite |  | Submit date：2018/12/18
Cardiovascular responses mediated by protease-activated receptor-2 (PAR- 2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR- 2 or PAR-1 Journal article
Damiano B.P., Cheung W.-M., Santulli R.J., Fung-Leung W.-P., Ngo K., Ye R.D., Darrow A.L., Derian C.K., De Garavilla L., Andrade-Gordon P.. Cardiovascular responses mediated by protease-activated receptor-2 (PAR- 2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR- 2 or PAR-1[J]. Journal of Pharmacology and Experimental Therapeutics, 1999, 288(2), 671-678.
Authors:  Damiano B.P.;  Cheung W.-M.;  Santulli R.J.;  Fung-Leung W.-P.;  Ngo K.; et al.
Favorite |  | Submit date：2018/11/07